Idiopathic thrombocytopenic purpura in tuberculosis (Case Report)

Marsela Shani, Drita Jaka GP
{"title":"Idiopathic thrombocytopenic purpura in tuberculosis (Case Report)","authors":"Marsela Shani, Drita Jaka GP","doi":"10.31579/2690-8808/121","DOIUrl":null,"url":null,"abstract":"Tuberculosis (TB) is a contagious disease in both developing and developed countries. The incidence is increasing due to bacilli resistant to many drugs and the human immunodeficiency virus (HIV). Since 2012, India has the highest incidence of the disease at around 2.2 million cases, accounting for 26% of the global incidence according to World Health Organization statistics. A wide range of hematological manifestations is observed in TB, where thrombocytopenia is common in miliary TB and thrombocytosis in pulmonary TB. Immune thrombocytopenic purpura (ITP) is characterized by a low platelet count accompanied by the presence of autoantibodies. The association of immune thrombocytopenic purpura and tuberculosis is a rare condition. In the case presented, anti-tuberculosis therapy was effective for both tuberculosis and thrombocytopenia, suggesting a causal link between tuberculosis and immune thrombocytopenic purpura. Purpose: Reporting a case of association of PTI and TBC Method: Clinical case study and correlation with literature Discussion: The pathophysiology of thrombocytopenia in tuberculosis remains unanswered. This is a rare condition, estimated to occur in less than 1% of tuberculosis cases. Mycobacterium tuberculosis can break down the antigen with platelets leading to the formation of antiplatelet antibodies. HLA-specific presentation of tuberculosis may also lead to an antiplatelet immune response in some patients.","PeriodicalId":193196,"journal":{"name":"Journal of Clinical Case Reports & Studies","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Case Reports & Studies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31579/2690-8808/121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Tuberculosis (TB) is a contagious disease in both developing and developed countries. The incidence is increasing due to bacilli resistant to many drugs and the human immunodeficiency virus (HIV). Since 2012, India has the highest incidence of the disease at around 2.2 million cases, accounting for 26% of the global incidence according to World Health Organization statistics. A wide range of hematological manifestations is observed in TB, where thrombocytopenia is common in miliary TB and thrombocytosis in pulmonary TB. Immune thrombocytopenic purpura (ITP) is characterized by a low platelet count accompanied by the presence of autoantibodies. The association of immune thrombocytopenic purpura and tuberculosis is a rare condition. In the case presented, anti-tuberculosis therapy was effective for both tuberculosis and thrombocytopenia, suggesting a causal link between tuberculosis and immune thrombocytopenic purpura. Purpose: Reporting a case of association of PTI and TBC Method: Clinical case study and correlation with literature Discussion: The pathophysiology of thrombocytopenia in tuberculosis remains unanswered. This is a rare condition, estimated to occur in less than 1% of tuberculosis cases. Mycobacterium tuberculosis can break down the antigen with platelets leading to the formation of antiplatelet antibodies. HLA-specific presentation of tuberculosis may also lead to an antiplatelet immune response in some patients.
肺结核并发特发性血小板减少性紫癜(1例报告)
结核病在发展中国家和发达国家都是一种传染性疾病。由于杆菌对许多药物和人类免疫缺陷病毒(HIV)具有耐药性,发病率正在增加。根据世界卫生组织的统计数据,自2012年以来,印度的发病率最高,约为220万例,占全球发病率的26%。在结核病中观察到广泛的血液学表现,其中血小板减少常见于军旅性结核病,血小板增多常见于肺结核。免疫性血小板减少性紫癜(ITP)的特点是血小板计数低并伴有自身抗体的存在。免疫性血小板减少性紫癜与结核的关联是一种罕见的情况。在这个病例中,抗结核治疗对肺结核和血小板减少症都有效,这表明肺结核和免疫性血小板减少性紫癜之间存在因果关系。目的:报告1例PTI与TBC相关病例方法:临床病例研究及文献相关性讨论:肺结核患者血小板减少的病理生理机制尚不明确。这是一种罕见的情况,估计发生在不到1%的结核病病例中。结核分枝杆菌可以用血小板分解抗原,从而形成抗血小板抗体。在一些患者中,hla特异性结核也可能导致抗血小板免疫反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信